Lixian Jiang
Directeur des opérations chez Cz Biomed Corp.
Profil
Lixian Jiang is currently the Chief Operating Officer & Vice President at Cz Biomed Corp.
Prior to this, he worked as the Chief Operating Officer at Stem Cell Therapy International, Inc. and as the Chief Operating Officer-China Division at AmStem Corp.
He holds a doctorate degree from the University of South Florida.
Postes actifs de Lixian Jiang
| Sociétés | Poste | Début |
|---|---|---|
Cz Biomed Corp.
 Cz Biomed Corp. BiotechnologyHealth Technology Cz Biomed Corp. operates as a biotechnology company. The company was founded by Calvin Cao in 2009 and is headquartered in Tampa, Florida. | Directeur des opérations | - |
Anciens postes connus de Lixian Jiang
| Sociétés | Poste | Fin |
|---|---|---|
Stem Cell Therapy International, Inc.
 Stem Cell Therapy International, Inc. Miscellaneous Commercial ServicesCommercial Services Stem Cell Therapy International, Inc. is a surgical procedure that has been used successfully for 70+ years as a treatment of many diseases for which modern medicine has had no therapy, or in which 'state-of-art' therapies stopped being effective. A documented 5 millions of patients have been so treated worldwide to-date, evidenced by over 120,000 publications in MEDLINE amongst others. SCT is approved for use by the German authorities and the EU. | Directeur des opérations | 09/02/2010 |
AmStem Corp.
 AmStem Corp. Pharmaceuticals: OtherHealth Technology AmStem Corp. researches and develops stem cell transplantation therapy and regenerative medicine. The company owns cord blood stem cell bank in Korea. The company was founded on December 28, 1992 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 09/02/2010 |
Formation de Lixian Jiang
| University of South Florida | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Stem Cell Therapy International, Inc.
Stem Cell Therapy International, Inc. Miscellaneous Commercial ServicesCommercial Services Stem Cell Therapy International, Inc. is a surgical procedure that has been used successfully for 70+ years as a treatment of many diseases for which modern medicine has had no therapy, or in which 'state-of-art' therapies stopped being effective. A documented 5 millions of patients have been so treated worldwide to-date, evidenced by over 120,000 publications in MEDLINE amongst others. SCT is approved for use by the German authorities and the EU. | Commercial Services |
AmStem Corp.
AmStem Corp. Pharmaceuticals: OtherHealth Technology AmStem Corp. researches and develops stem cell transplantation therapy and regenerative medicine. The company owns cord blood stem cell bank in Korea. The company was founded on December 28, 1992 and is headquartered in San Francisco, CA. | Health Technology |
Cz Biomed Corp.
Cz Biomed Corp. BiotechnologyHealth Technology Cz Biomed Corp. operates as a biotechnology company. The company was founded by Calvin Cao in 2009 and is headquartered in Tampa, Florida. | Health Technology |